Menu
Search
|

Menu

Close
X

SenesTech Inc SNES.OQ (NASDAQ Stock Exchange Capital Market)

1.63 USD
+0.28 (+20.74%)
As of Jul 14
chart
Previous Close 1.35
Open 1.62
Volume 795,167
3m Avg Volume 290,006
Today’s High 1.84
Today’s Low 1.45
52 Week High 5.45
52 Week Low 0.30
Shares Outstanding (mil) 10.32
Market Capitalization (mil) 19.00
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
FY15
0
EPS (USD)
FY18
-0.162
FY17
-1.153
FY16
-1.332
FY15
-1.505
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
92.67
5.73
Price to Book (MRQ)
vs sector
3.35
5.45
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
14.52
16.72
LT Debt to Equity (MRQ)
vs sector
11.34
12.39
Return on Investment (TTM)
vs sector
-289.56
14.61
Return on Equity (TTM)
vs sector
-19,510.14
16.34

EXECUTIVE LEADERSHIP

Loretta Mayer
Chairman of the Board, Chief Executive Officer, Chief Scientific Officer, Since 2004
Salary: $107,000.00
Bonus: $81,836.00
Cheryl Dyer
President, Chief Research Officer, Director, Since 2004
Salary: $107,000.00
Bonus: $60,000.00
Grover Wickersham
Independent Vice Chairman of the Board, Since 2015
Salary: --
Bonus: --
Thomas Chesterman
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary, Since 2015
Salary: --
Bonus: --
Kim Wolin
Executive Vice President - Operations, Secretary, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

3140 N Caden Ct Ste 1
FLAGSTAFF   AZ   86004-9428

Phone: +1928.7794143

SenesTech, Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest's technology and approach targets the reproductive capabilities of both sexes. Using bait stations, ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rodent communities. Its formulation causes both female and male rats to become infertile once they have consumed the dose. The active ingredient in females accelerates the rate at which ovarian follicles (egg structures) are depleted. Once these cells are gone, the animal cannot reproduce. In males, there is a marked reduction in the ability to fertilize eggs and, often complete sterility. ContraPest is designed, formulated and dispensed for handlers and non-target species, such as wildlife and pets in a biodegradable product.

SPONSORED STORIES